Bank of the West’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $12.4M | Sell |
111,961
-5,578
| -5% | -$570K | 1.46% | 15 |
|
|
2022
Q3 | $10.1M | Sell |
117,539
-1,715
| -1% | -$153K | 1.32% | 17 |
|
|
2022
Q2 | $10.9M | Buy |
119,254
+4,531
| +4% | +$402K | 1.38% | 16 |
|
|
2022
Q1 | $9.41M | Buy |
114,723
+4,643
| +4% | +$366K | 0.97% | 27 |
|
|
2021
Q4 | $8.44M | Buy |
110,080
+3,668
| +3% | +$292K | 0.8% | 35 |
|
|
2021
Q3 | $7.99M | Buy |
106,412
+9,480
| +10% | +$721K | 0.84% | 30 |
|
|
2021
Q2 | $7.54M | Sell |
96,932
-11,738
| -11% | -$873K | 0.77% | 34 |
|
|
2021
Q1 | $7.99M | Sell |
108,670
-2,842
| -3% | -$210K | 0.9% | 28 |
|
|
2020
Q4 | $8.7M | Sell |
111,512
-3,778
| -3% | -$289K | 1.02% | 24 |
|
|
2020
Q3 | $9.13M | Sell |
115,290
-6,498
| -5% | -$509K | 1.23% | 19 |
|
|
2020
Q2 | $8.99M | Buy |
121,788
+39,593
| +48% | +$2.98M | 1.21% | 19 |
|
|
2020
Q1 | $6.04M | Buy |
82,195
+34,277
| +72% | +$2.69M | 0.94% | 25 |
|
|
2019
Q4 | $4.16M | Sell |
47,918
-2,727
| -5% | -$224K | 0.49% | 57 |
|
|
2019
Q3 | $4.07M | Buy |
50,645
+16,215
| +47% | +$1.3M | 0.49% | 55 |
|
|
2019
Q2 | $2.75M | Sell |
34,430
-1,852
| -5% | -$142K | 0.32% | 86 |
|
|
2019
Q1 | $2.88M | Sell |
36,282
-1,852
| -5% | -$139K | 0.34% | 83 |
|
|
2018
Q4 | $2.78M | Buy |
38,134
+245
| +0.6% | +$17.3K | 0.33% | 85 |
|
|
2018
Q3 | $2.56M | Buy |
37,889
+2,784
| +8% | +$177K | 0.3% | 96 |
|
|
2018
Q2 | $2.03M | Buy |
35,105
+90
| +0.3% | +$5.08K | 0.25% | 109 |
|
|
2018
Q1 | $1.82M | Buy |
35,015
+2,448
| +8% | +$132K | 0.23% | 123 |
|
|
2017
Q4 | $1.75M | Buy |
32,567
+1,552
| +5% | +$86K | 0.22% | 122 |
|
|
2017
Q3 | $1.9M | Buy |
31,015
+279
| +0.9% | +$16.9K | 0.24% | 119 |
|
|
2017
Q2 | $1.88M | Buy |
30,736
+787
| +3% | +$47.9K | 0.24% | 118 |
|
|
2017
Q1 | $1.81M | Buy |
29,949
+373
| +1% | +$22.6K | 0.23% | 118 |
|
|
2016
Q4 | $1.66M | Buy |
29,576
+1,005
| +4% | +$58.8K | 0.23% | 120 |
|
|
2016
Q3 | $1.7M | Buy |
28,571
+246
| +0.9% | +$14.4K | 0.23% | 116 |
|
|
2016
Q2 | $1.56M | Sell |
28,325
-1,039
| -4% | -$55.3K | 0.22% | 123 |
|
|
2016
Q1 | $1.48M | Sell |
29,364
-246
| -0.8% | -$12K | 0.2% | 126 |
|
|
2015
Q4 | $1.49M | Sell |
29,610
-4,356
| -13% | -$220K | 0.21% | 122 |
|
|
2015
Q3 | $1.6M | Sell |
33,966
-6,894
| -17% | -$366K | 0.26% | 112 |
|
|
2015
Q2 | $2.22M | Sell |
40,860
-454
| -1% | -$25.5K | 0.32% | 96 |
|
|
2015
Q1 | $2.27M | Buy |
41,314
+131
| +0.3% | +$7.42K | 0.32% | 99 |
|
|
2014
Q4 | $2.23M | Buy |
41,183
+512
| +1% | +$28.5K | 0.33% | 101 |
|
|
2014
Q3 | $2.3M | Sell |
40,671
-5,012
| -11% | -$281K | 0.39% | 86 |
|
|
2014
Q2 | $2.52M | Sell |
45,683
-1,391
| -3% | -$75.9K | 0.39% | 87 |
|
|
2014
Q1 | $2.55M | Sell |
47,074
-11,928
| -20% | -$618K | 0.42% | 83 |
|
|
2013
Q4 | $2.82M | Buy |
59,002
+5,585
| +10% | +$255K | 0.45% | 74 |
|
|
2013
Q3 | $2.43M | Sell |
53,417
-696
| -1% | -$31.8K | 0.44% | 80 |
|
|
2013
Q2 | $2.4M | Buy |
+54,113
| New | +$2.42M | 0.45% | 78 |
|
Other funds holding MRK
AWA
Bank of the West's MRK Position: Q4 2022 in Review
Bank of the West reduced its Merck (MRK) stake by 4.7% in Q4 2022, selling an estimated $570K and leaving 111,961 shares worth $12.4M. The position accounts for 1.46% of the portfolio, ranked #15.
Bank of the West first reported a position in MRK in Q2 2013 and has held it in 39 quarters since. 3,235 funds tracked by Wall St. Rank hold MRK as of Q4 2022.
- Bank of the West held 111,961 shares of Merck worth $12.4M as of Q4 2022.
- Bank of the West sold 5,578 Merck shares in Q4 2022, an estimated $570K.
- Merck made up 1.46% of Bank of the West's portfolio in Q4 2022, its #15 holding.
- Bank of the West first reported a position in Merck in Q2 2013 and has held it in 39 quarters since.
- 3,235 funds tracked by Wall St. Rank held Merck as of Q4 2022.
Based on Bank of the West's 13F filing for Q4 2022, filed 1 Feb 2023.